Keywords
Albuminuria
Obesity
Kidney function
Health workers
Estimated glomerular filtration rate eGFR
How to Cite
Abstract
Background: Chronic kidney disease (CKD) affects approximately 10% of the adult population worldwide, with a particularly high prevalence in developed countries. This condition is closely related to factors such as obesity and diabetes, which are common comorbidities in affected patients. Healthcare workers are not exempt from presenting markers of kidney damage and CKD.
Purpose: To determine the prevalence of CKD, defined as estimated GFR < 60 mL/min/1.73m2 and/or albuminuria/creatinuria ratio (ACR) > 30 mg/g, among a sample of Colombian nephrologists attending the XXV Symposium of Nephrology, Dialysis and Transplant.
Methodology: Cross-sectional study, convenience sampling. A protocolized survey was carried out with variables of interest and serum samples were taken for creatinine and occasional urine to measure the albuminuria-creatinuria ratio. GFR was calculated by CKD EPI 2009 and 2021.
Results: 73 participants were included from a total of 200 nephrologists, the majority being male 57 (78%), with an average BMI of 26.8 ± 4.7. The frequency of GFR due to CKD-epi between 60 and 90 ml/min was 83% (n 60), the mean ACR was 26.2 ± 7.0 mg/g. 16 nephrologists had ACR in category A2, which corresponds to 21.9% of the sample. 14 of the 16 patients with A2 albuminuria were overweight or obese. An analysis categorized by BMI demonstrated a relationship between BMI >=25 and the presence of albuminuria A2 p 0.003
Conclusions: The population of nephrologists in the total sample has a high BMI and both overweight and obesity were correlated with the presence of A2 albuminuria, with a prevalence of 21.9% of this category of albuminuria.
References
Yu AS, Chertow GM, Luyckx V, Marsden PA, Skorecki K, Taal MW. Brenner y Rector. El riñón. 11.a ed. Filadelfia. Estados Unidos: Elsevier; 2020. 3529 p.
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33. https://doi.org/10.1016/s0140-6736(20)30045-3
Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1):e007525. https://doi.org/10.1136/bmjgh-2021-007525
Ulasi II, Awobusuyi O, Nayak S, Ramachandran R, Musso CG, Depine SA, et al. Chronic kidney disease burden in low-resource settings: regional perspectives. Semin Nephrol. 2022;42(5):151336. https://doi.org/10.1016/j.semnephrol.2023.151336
Cuenta de Alto Costo. ¿Qué es ERC? [internet]. Bogotá: CAC; 2021 [citado 2023 ag. 8]. https://cuentadealtocosto.org/erc/
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1). https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294-304. https://doi.org/10.1001/jama.2019.14745
National Kidney Foundation. National Kidney Foundation, American Society for Clinical Pathology, leading laboratories and clinical laboratory societies unite to diagnose chronic kidney disease [internet]. Nueva York: National Kidney Foundation; 2018 [citado 2023 jul. 29]. https://www.kidney.org/news/national-kidney-foundation-american-society-clinical-pathology-leading-laboratories-and
Gaitonde DY, Cook DL, Rivera IM. Chronic kidney disease: detection and evaluation. Am Fam Physician. 2017;96(12):776-83.
Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, et al. CKD: a call for an age-adapted definition. J Am Soc Nephrol. 2019;30(10):1785-805. https://doi.org/10.1681/asn.2019030238
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305. https://doi.org/10.1056/nejmoa041031
Belkic KL, Landsbergis PA, Schnall PL, Baker D. Is job strain a major source of cardiovascular disease risk? Scand J Work Environ Health. 2004;30(2):85-128. https://doi.org/10.5271/sjweh.769
Liao MH, Lai YC, Lin CM. Cardiovascular risk factors in hospital workers during the COVID-19 pandemic: a hospital-based repeated measures study. Int J Environ Res Public Health. 2022;19(23):16114. https://doi.org/10.3390/ijerph192316114
Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395-406. https://doi.org/10.1053/j.ajkd.2007.11.018
Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20(8):1813-21. https://doi.org/10.1681/asn.2008121270
Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju S, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776-86. https://doi.org/10.1016/s0140-6736(16)30175-1
Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26(1):28-35. https://doi.org/10.1093/ndt/gfq576
Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. Eur J Prev Cardiol. 2022;29(17):2218-37. https://doi.org/10.1093/eurjpc/zwac187
Ren M, Sun K, Li F, Qi YQ, Lin DZ, Li N, et al. Association between obesity measures and albuminuria: a population-based study. J Diabetes Complications. 2016;30(3):451-6. https://doi.org/10.1016/j.jdiacomp.2015.12.007
Sarafidis PA. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens. 2008;17(5):450-6. https://doi.org/10.1097/mnh.0b013e328305b994
Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res. 2012;35(1):4-16. https://doi.org/10.1038/hr.2011.173
Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(3):550-62. https://doi.org/10.2215/cjn.04071206
Briffa JF, McAinch AJ, Poronnik P, Hryciw DH. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013 Dec 15;305(12):F1629-36. https://doi.org/10.1152/ajprenal.00263.2013
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.